世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034264

自己免疫疾患治療薬の世界市場(2023-2027)

TechNavio

Global Autoimmune Drugs Market 2023-2027

発刊日 2023/01/20

言語英語

体裁PDF/173ページ

ライセンス/価格173ページ

0000034264

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、自己免疫疾患治療薬市場を分析します。

世界の自己免疫疾患治療薬市場は、予測期間中に約6.39 %のCAGRで加速し、2022年から2027年の間に293億1,450万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場を牽引するのは、強力な研究開発パイプライン、生物製剤の標的治療メカニズム、手頃な価格のバイオシミラーの導入などです。

調査範囲

  • 市場セグメント
    ➣ 治療領域別
    ➣ 関節リウマチ
    ➣ 多発性硬化症
    ➣ 乾癬
    ➣ 炎症性腸疾患
    ➣ その他
    ➣ 流通チャネル別
      ◇ 病院
      ◇ 薬局
      ◇ ドラッグストア・小売薬局
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、自己免疫疾患治療薬のコスト削減が、今後数年間の自己免疫疾患治療薬市場の成長を促進する主要因の1つであると位置づけています。また、TNFα阻害薬による市場の支配と新薬の開発・承認が、市場の大きな需要につながると考えています。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 自己免疫疾患治療薬の市場規模
  • 自己免疫疾患治療薬の市場予測
  • 自己免疫疾患治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な自己免疫疾患治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ AbbVie Inc.
    ➣ AdvaCare Pharma
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Bristol Myers Squibb Co.
    ➣ Cardinal Health Inc.
    ➣ Delphis Pharmaceutical India
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Hikma Pharmaceuticals Plc
    ➣ Johnson and Johnson
    ➣ Medexus Pharmaceuticals Inc.
    ➣ Parvus Therapeutics Inc.
    ➣ Prometheus Laboratories Inc.
    ➣ Regeneron Pharmaceuticals Inc.
    ➣ Sanofi SA
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Wellona Pharma

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global autoimmune drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
4.2 Therapy area Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy Area
6.1 Market segments
Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
6.2 Comparison by Therapy Area
Exhibit 32: Chart on Comparison by Therapy Area
Exhibit 33: Data Table on Comparison by Therapy Area
6.3 Rheumatoid arthritis - Market size and forecast 2022-2027
Exhibit 34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
6.4 Multiple sclerosis - Market size and forecast 2022-2027
Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
6.5 Psoriasis - Market size and forecast 2022-2027
Exhibit 42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
6.6 Inflammatory bowel disease - Market size and forecast 2022-2027
Exhibit 46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Therapy Area
Exhibit 54: Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 57: Chart on Comparison by Distribution Channel
Exhibit 58: Data Table on Comparison by Distribution Channel
7.3 Hospital - Market size and forecast 2022-2027
Exhibit 59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
7.4 Pharmacy - Market size and forecast 2022-2027
Exhibit 63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Drug store/Retail pharmacy - Market size and forecast 2022-2027
Exhibit 67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Online - Market size and forecast 2022-2027
Exhibit 71: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Distribution Channel
Exhibit 75: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 77: Chart on Market share by geography 2022-2027 (%)
Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 79: Chart on Geographic comparison
Exhibit 80: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 113: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 115: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 116: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 118: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 120: Overview on factors of disruption
11.4 Industry risks
Exhibit 121: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 122: Vendors covered
12.2 Market positioning of vendors
Exhibit 123: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 124: AbbVie Inc. - Overview
Exhibit 125: AbbVie Inc. - Product / Service
Exhibit 126: AbbVie Inc. - Key news
Exhibit 127: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 128: Amgen Inc. - Overview
Exhibit 129: Amgen Inc. - Product / Service
Exhibit 130: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 131: AstraZeneca Plc - Overview
Exhibit 132: AstraZeneca Plc - Product / Service
Exhibit 133: AstraZeneca Plc - Key news
Exhibit 134: AstraZeneca Plc - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 135: Bristol Myers Squibb Co. - Overview
Exhibit 136: Bristol Myers Squibb Co. - Product / Service
Exhibit 137: Bristol Myers Squibb Co. - Key news
Exhibit 138: Bristol Myers Squibb Co. - Key offerings
12.7 Cardinal Health Inc.
Exhibit 139: Cardinal Health Inc. - Overview
Exhibit 140: Cardinal Health Inc. - Business segments
Exhibit 141: Cardinal Health Inc. - Key news
Exhibit 142: Cardinal Health Inc. - Key offerings
Exhibit 143: Cardinal Health Inc. - Segment focus
12.8 Delphis Pharmaceutical India
Exhibit 144: Delphis Pharmaceutical India - Overview
Exhibit 145: Delphis Pharmaceutical India - Product / Service
Exhibit 146: Delphis Pharmaceutical India - Key offerings
12.9 Eli Lilly and Co.
Exhibit 147: Eli Lilly and Co. - Overview
Exhibit 148: Eli Lilly and Co. - Product / Service
Exhibit 149: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 155: GlaxoSmithKline Plc - Overview
Exhibit 156: GlaxoSmithKline Plc - Business segments
Exhibit 157: GlaxoSmithKline Plc - Key offerings
Exhibit 158: GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 159: Hikma Pharmaceuticals Plc - Overview
Exhibit 160: Hikma Pharmaceuticals Plc - Business segments
Exhibit 161: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 162: Hikma Pharmaceuticals Plc - Segment focus
12.13 Johnson and Johnson
Exhibit 163: Johnson and Johnson - Overview
Exhibit 164: Johnson and Johnson - Business segments
Exhibit 165: Johnson and Johnson - Key news
Exhibit 166: Johnson and Johnson - Key offerings
Exhibit 167: Johnson and Johnson - Segment focus
12.14 Parvus Therapeutics Inc.
Exhibit 168: Parvus Therapeutics Inc. - Overview
Exhibit 169: Parvus Therapeutics Inc. - Product / Service
Exhibit 170: Parvus Therapeutics Inc. - Key offerings
12.15 Sanofi SA
Exhibit 171: Sanofi SA - Overview
Exhibit 172: Sanofi SA - Business segments
Exhibit 173: Sanofi SA - Key news
Exhibit 174: Sanofi SA - Key offerings
Exhibit 175: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 178: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 179: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy Area ($ million)
Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits75: Market opportunity by Distribution Channel ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share by geography 2022-2027 (%)
Exhibits78: Data Table on Market share by geography 2022-2027 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits113: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits117: Market opportunity by geography ($ million)
Exhibits118: Impact of drivers and challenges in 2022 and 2027
Exhibits119: Overview on Criticality of inputs and Factors of differentiation
Exhibits120: Overview on factors of disruption
Exhibits121: Impact of key risks on business
Exhibits122: Vendors covered
Exhibits123: Matrix on vendor position and classification
Exhibits124: AbbVie Inc. - Overview
Exhibits125: AbbVie Inc. - Product / Service
Exhibits126: AbbVie Inc. - Key news
Exhibits127: AbbVie Inc. - Key offerings
Exhibits128: Amgen Inc. - Overview
Exhibits129: Amgen Inc. - Product / Service
Exhibits130: Amgen Inc. - Key offerings
Exhibits131: AstraZeneca Plc - Overview
Exhibits132: AstraZeneca Plc - Product / Service
Exhibits133: AstraZeneca Plc - Key news
Exhibits134: AstraZeneca Plc - Key offerings
Exhibits135: Bristol Myers Squibb Co. - Overview
Exhibits136: Bristol Myers Squibb Co. - Product / Service
Exhibits137: Bristol Myers Squibb Co. - Key news
Exhibits138: Bristol Myers Squibb Co. - Key offerings
Exhibits139: Cardinal Health Inc. - Overview
Exhibits140: Cardinal Health Inc. - Business segments
Exhibits141: Cardinal Health Inc. - Key news
Exhibits142: Cardinal Health Inc. - Key offerings
Exhibits143: Cardinal Health Inc. - Segment focus
Exhibits144: Delphis Pharmaceutical India - Overview
Exhibits145: Delphis Pharmaceutical India - Product / Service
Exhibits146: Delphis Pharmaceutical India - Key offerings
Exhibits147: Eli Lilly and Co. - Overview
Exhibits148: Eli Lilly and Co. - Product / Service
Exhibits149: Eli Lilly and Co. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: GlaxoSmithKline Plc - Overview
Exhibits156: GlaxoSmithKline Plc - Business segments
Exhibits157: GlaxoSmithKline Plc - Key offerings
Exhibits158: GlaxoSmithKline Plc - Segment focus
Exhibits159: Hikma Pharmaceuticals Plc - Overview
Exhibits160: Hikma Pharmaceuticals Plc - Business segments
Exhibits161: Hikma Pharmaceuticals Plc - Key offerings
Exhibits162: Hikma Pharmaceuticals Plc - Segment focus
Exhibits163: Johnson and Johnson - Overview
Exhibits164: Johnson and Johnson - Business segments
Exhibits165: Johnson and Johnson - Key news
Exhibits166: Johnson and Johnson - Key offerings
Exhibits167: Johnson and Johnson - Segment focus
Exhibits168: Parvus Therapeutics Inc. - Overview
Exhibits169: Parvus Therapeutics Inc. - Product / Service
Exhibits170: Parvus Therapeutics Inc. - Key offerings
Exhibits171: Sanofi SA - Overview
Exhibits172: Sanofi SA - Business segments
Exhibits173: Sanofi SA - Key news
Exhibits174: Sanofi SA - Key offerings
Exhibits175: Sanofi SA - Segment focus
Exhibits176: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits177: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits178: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations

この商品のレポートナンバー

0000034264

TOP